- Devaluation of the Egyptian Pound
- Halted operations in Sudan due to conflict
- High inflation impacting cost of living for global workforce
- Data limitations for ethnic diversity survey due to GDPR and labor laws in some countries
Hikma Pharmaceuticals PLC
Greenhouse gas emissions & sustainability report data
Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
π Emissions by Report Period
| Report period | Headline emissions figure reported |
|---|---|
| 2022 | 123.1K tCO2e/year (Scope 1 & 2 market-based excluding RECs) |
| 2021 | 116.6K tCO2e (market-based) |
| 2020 | 124.4K tCO2e/year |
| 2015 | 26.5K tCO2e (Scope 1) and 83520 tCO2 (Scope 2) |
Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.
β Reported Environmental Achievements
- Reduced scope 1 and 2 emissions by 15%
π― Climate & Sustainability Targets
π Short-term
- Detailed review of executive succession plans
- Implementation and testing of fraud prevention program
- Enhance modern slavery disclosure
- Implement enhancements to internal controls
- Plan for externally facilitated Board and Committee effectiveness review
π Medium-term
- Review succession plans for Non-Executive Directors reaching nine years of service in 2025
- Increase gender diversity in MENA management positions
π Long-term
- Reduce scope 1 and 2 GHG emissions by 25% by 2030
- Achieve good water management at all Hikmaβs sites in MENA by 2025
π± ESG Focus Areas
Diversity, Equity and Inclusion (DEI)Environmental Sustainability (Emissions, Water Management)Ethical Conduct and Business IntegrityCorporate Social Responsibility